Facebook Feed

2 weeks ago

Yoram Ettinger
Purim Guide for the Perplexed 2023: bit.ly/3ZdlxHY ... See MoreSee Less
View on Facebook

2 weeks ago

Yoram Ettinger
אתגר מרכזי לביטחון לאומי: bit.ly/3xkSwh1 ... See MoreSee Less
View on Facebook

2 weeks ago

Yoram Ettinger
US-sponsored anti-Israel UN Security Council statement - acumen: bit.ly/3lVqpCM ... See MoreSee Less
View on Facebook

2 weeks ago

Yoram Ettinger
bit.ly/3xHPCDc הסכמי אברהם – אינטרס ערבי, אמריקאי וישראלי: ... See MoreSee Less
View on Facebook

Israel: 1st non-European President of R&D Eureka

 

1.  The Bio-Jerusalem Initiative has been established, in order to transform Jerusalem into the capital of Israel’s bio-med.  43% of Israel’s bio-med research is conducted in Jerusalem. 12% of Jerusalem’s workforce is engaged in bio-med and healthcare. Jerusalem’s Hebrew University is ranked 12th in the number of bio-med patents.  Hebrew U Ph.D. candidates in the areas of biology, medicine, pharmacology and chemistry constitute an exceptional potential for Jerusalem’s bio-med industries. The School of Pharmacology focuses on pharmaceutical development. Jerusalem’s BioLine incubator is bio-technology-oriented, receiving a $1.5MN grant from Israel’s chief-scientist, compared with $600,000 granted to other incubators.  Jerusalem’s Van Lear Incubator is top heavy on medical devices start-ups.  Hadassah Hospital established a center for clinical trials.  130 bio-med companies operate in Jerusalem (e.g. Teva, Medinol and Brainsway), which account to 35% of the total bio-med companies operating in Israel, second only to Rehovot.  During the last 3 years, the number of bio-med companies – in Jerusalem – grew by 27% and the number of bio-med workers grew by 40%.   

 

2.  Microsoft’s CEO, Steve Balmer: “Microsoft is as much an Israeli company as an American company, because of the importance of its Israeli technologies (Wall St. Journal, Nov. 23m 2009). Microsoft’s Israeli acquisitions: Gteko (2006 – $120MN), Kidaro (2008 – $100MN), Whale (2006 – $76MN), Peach (2000 – $72MN), Zoomix (2008 – $30MN), YaData (2008 – $25MN), Olap Technologies (1996 – $20MN), MaxiMal (2001 – $20MN), Felican (2003 – $800,000), WebPoint – unavailable, Secured Dimension – unavailable) – Globes, June 29, 2010.

 

3.  The US-Israel Bi-national R&D (BIRD) Foundation has sponsored over 800 joint US-Israel projects, which yielded more than $8BN in sales for the beneficiary companies.  The matching-funds Foundation considers an expansion of $30MN by each country (Globes, June 18).

 

4.  Israel is the first non-European country to be elected as the President of Eureka (July 2010), the leading industrial inter-governmental European R&D program and the largest of its kind in the world. The share of Israeli companies in Eureka projects has exceeded 10%, far beyond the size of Israel’s economy.   

 

5.  Israel’s Vringo raised $11MN on AMEX, which is owned by the NYSE (Globes, June 25).

 

6.  The Santa Clara-based Atheros is leading – along with Sequoia Capital, Benchmark Capital and Tallwood Venture Capital – a $20MN  3rd round of private placement by Israel’s Wilocity (Globes, July 15).  Sequoia Capital co-led a $6MN 2nd round by Israel’s Snaptu (Globes, June 24).  




Videos

The post-1967 turning point of US-Israel cooperation

Israeli benefits to the US taxpayer exceed US foreign aid to Israel

Iran - A Clear And Present Danger To The USA

Exposing the myth of the Arab demographic time bomb

Israel’s Covid-19 Economic Trends

Straight from the Jerusalem Boardroom #248
https://bit.ly/3u29k9g

Foreign investment in Israel’s high-tech companies surged to new heights in the 1st quarter of 2021 – $5.7bn in 172 deals – which is up 89% over the impressive 4th quarter of 2020 and double the volume of the 1st quarter of 2020.

2020 was the first year of surpassing $10bn in capital raised by the Israeli high-tech sector from investors in the US, Asia and Europe, who trust the maturity of Israel’s brain power. Investments in Israeli companies more than tripled in six years, reflecting the effective response by Israeli startups to the technological, medical, pharmaceutical, educational, social and digital challenges posed by Covid-19.

Israel’s economic performance in defiance of Covid-19 is presented by Dr. Adam Reuter, the Chairman and Founder of “Financial Immunities,” Israel’s largest financial-risk management firm, and the co-author of Israel – Island of Success:

  1. Israel has led the globe in the rapid administration of Covid-19 vaccinations due to effective negotiations with Pfizer and an efficient, country-wide medical infrastructure.
  2. Israel is the second lowest among OECD countries in the number of Covid-19 deaths per number of Covid-19 cases: 0.7% compared to the 2.3% OECD average. Israel features a young population (median age of 30 compared to the OECD’s 42) and an effective country-wide medical infrastructure, including top level HMOs and hospitals.
  3. Israel is ranked 12th from the bottom among the 37 OECD countries in the number of deaths per million inhabitants: 645 compared to 1,145 OECD average.
  4. The International Monetary Fund’s 2025 GDP growth forecast for OECD countries: Israel – 4%, OECD average – 2.2%, US – 1.8%, Australia – 2.5%, Ireland – 2.6%, France and Canada – 1.7%, the UK – 1.6%, Germany – 1.2%, etc.
  5. Israel’s 2020 GDP was reduced by 2.5%, compared to the OECD average reduction of 4.1%, South Korea – 1%, Norway – 0.8%, Australia – 2.6%, US – 3.5%, Japan – 4.8%, Germany – 5%, France – 8%, the UK – 10% reduction, etc. GDP growth was recorded in New Zealand – 2.4% and Ireland – 3.5%.
  6. In 2020, Israel was ranked 20th among the 37 members of the OECD in terms of GDP per capita, featuring $43,000 (GDP – $408bn), ahead of Japan, Italy and Spain, and very close behind the UK ($44,000) and France ($45,000).
  7. Israel’s debt-to-GDP ratio increased from 60% in 2019 to 72% in 2020, compared to the OECD’s average increase from 66% to 82%. The 2020’s debt-to-GDP ratio was 266% in Japan, Italy – 161%, the US – 131%, Germany – 73%, etc.
  8. Israel’s foreign exchange reserves-to-GDP ratio of 41% (3rd among the OECD countries) attests to its financial stability, and Israel’s capability to raise foreign credit promptly in a cost-effective manner. Israel’s foreign exchange reserves in March 2021 – $186bn.
  9. During the past decade, Standard and Poor (S&P) accorded Israel a positive credit rating trend, unlike the negative trend for the G-7 countries. In 2020, notwithstanding Covid-19, Israel’s credit rating (S&P) remained at AA.
  10. Some 380 global high-tech giants operate in Israel, including Microsoft, Amazon, IBM, Intel, Cisco, Apple, Verizon, Applied Materials, Dell, HP, Kodak, Oracle, Philips, SAP, Medtronics, GM, eBay, GE, etc. Israel leads the world in the ratio of research and development investment to GDP: 4.9%. 85% of this investment comes from the business sector.

 




Videos

The post-1967 turning point of US-Israel cooperation

Israeli benefits to the US taxpayer exceed US foreign aid to Israel

Iran - A Clear And Present Danger To The USA

Exposing the myth of the Arab demographic time bomb